MAZE - Latest News
Maze Therapeutics, Inc. (MAZE), operates in Healthcare / Biotechnology, trades on NASDAQ.
Market capitalization stands near $1.49B. Beta to the broader market is 2.50.
The article list below shows the most recent MAZE headlines from major financial news vendors. For options traders, the most actionable items are earnings releases, analyst rating changes, M&A activity, and regulatory filings - each can drive a meaningful repricing of implied volatility and shift dealer hedging flow. Pair the news context with the implied-volatility skew and gamma exposure views to see whether the options market has already priced in the headline.
Recent MAZE Headlines
Maze Therapeutics, Inc. (MAZE) Reports Q1 Loss, Beats Revenue Estimates
zacks.com - May 12, 2026
Maze Therapeutics, Inc. (MAZE) came out with a quarterly loss of $0.
Maze Therapeutics Reports First Quarter 2026 Financial Results and Recent Highlights
globenewswire.com - May 12, 2026
Positive topline data from Phase 2 HORIZON trial of MZE829 in patients with broad AMKD provide proof-of-concept and support advancement into pivotal t
Maze Therapeutics CSBO Sells 7,500 Shares for $190,000 After Strong Trial Results and Q4 Financials
fool.com - May 7, 2026
This clinical-stage biotech focused on precision medicines for renal and metabolic diseases just reported a notable insider sale.
Maze Therapeutics Announces $150 Million Registered Offering
globenewswire.com - Apr 22, 2026
SOUTH SAN FRANCISCO, Calif. , April 22, 2026 (GLOBE NEWSWIRE) -- Maze Therapeutics, Inc.
Maze Therapeutics' Chief Medical Officer Sold 100% of His Direct Holdings. Here's What This Means for Investors.
fool.com - Apr 4, 2026
Chief Medical Officer Harold Bernstein sold 15,000 company shares for a transaction value of ~$442,000 at around $29. 46 per share on April 1, 2026.
How News Affects MAZE Options Pricing
Headlines and scheduled events drive implied volatility in two distinct ways. Pre-event, IV typically inflates as uncertainty about the outcome rises; this is the implied-volatility expansion that creates the long-vol setup. Post-event, IV typically contracts sharply as uncertainty resolves; this is IV crush, which makes premium-selling structures profitable when they survive the underlying move. The size of the crush depends on how stretched pre-event IV is relative to the realized move. Track MAZE's implied vs realized volatility over the news cycle to size pre-event vs post-event positioning. For ticker-level dealer positioning context, the gamma exposure view shows whether dealers are positioned to amplify or dampen post-news moves.
Frequently asked MAZE news questions
- What is the latest MAZE news headline?
- The most recent MAZE headline (May 12, 2026) is "Maze Therapeutics, Inc. (MAZE) Reports Q1 Loss, Beats Revenue Estimates". The five most recent stories with summaries and publication times are listed above, sourced from major financial news vendors.
- How fresh is the MAZE news on this page?
- News rows refresh roughly every 30 minutes during the trading day. The five most recent headlines are listed in publication-time order. Press releases from the company itself typically appear within minutes of the wire release; third-party reporting may lag by 30-60 minutes depending on the source.
- What MAZE news moves options pricing?
- Three categories move single-name IV most aggressively: scheduled earnings releases (priced into pre-event IV, crushed post-event), unscheduled M&A or strategic announcements (rapid IV expansion, slower decay), and regulatory or legal events (drug-trial readouts, antitrust filings, FDA approvals). Routine news flow (analyst commentary, sector rotation) typically does not move IV meaningfully unless it triggers a cluster of rating changes.
- How can I track unusual MAZE options activity related to news?
- Unusual options activity often precedes news by hours to days; the canonical signals are volume substantially above the trailing average concentrated in a small number of strikes, atypical put/call skew, and aggressive execution (at-the-ask sweeps or block prints). Cross-reference the per-ticker gamma-exposure and volume-history pages with the news flow above to triangulate informed vs uninformed flow.